SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-019472
Filing Date
2024-01-30
Accepted
2024-01-30 16:40:59
Documents
15
Period of Report
2023-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d619190d8ka.htm   iXBRL 8-K/A 31758
2 EX-2.1 d619190dex21.htm EX-2.1 859374
  Complete submission text file 0001193125-24-019472.txt   1224314

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20231001.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20231001_lab.xml EX-101.LAB 17942
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20231001_pre.xml EX-101.PRE 11246
17 EXTRACTED XBRL INSTANCE DOCUMENT d619190d8ka_htm.xml XML 6317
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39695 | Film No.: 24578762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)